In Stock ARA-290 10MG is a 10-milligram format of ARA-290, an erythropoietin derived peptide analogue designed to model tissue protective signaling without erythropoietic activity
By building new pathways for blood to flow, BPC 157 delivers vital oxygen and nutrients directly to injured areas
The correct dosing sequence is Semax first (300600 mcg intranasal), followed by Selank (250500 mcg) 3045 minutes latersimultaneous administration creates muddy, inconsistent effects
Science Bio Click Here Now to visit the Science.bio page on BPC-157
Broux et al., In vitro BBB models have been crucial to establish links between inflammatory immune components and BBB degradation
Am J Med Genet B Neuropsychiatr Genet 174:93112 Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS, Wang JS, Chang VH, Pang JS (2017) Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation